KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Net Cash Flow (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Net Cash Flow for 11 consecutive years, with $210.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 1355.04% year-over-year to $210.9 million, compared with a TTM value of -$178.3 million through Dec 2025, down 141.81%, and an annual FY2025 reading of -$178.3 million, down 141.81% over the prior year.
  • Net Cash Flow was $210.9 million for Q4 2025 at Medpace Holdings, down from $239.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $239.0 million in Q3 2025 and bottomed at -$398.1 million in Q2 2025.
  • Average Net Cash Flow over 5 years is $11.3 million, with a median of $37.2 million recorded in 2023.
  • The sharpest move saw Net Cash Flow tumbled 764.14% in 2022, then skyrocketed 4199.56% in 2023.
  • Year by year, Net Cash Flow stood at $64.2 million in 2021, then crashed by 105.7% to -$3.7 million in 2022, then surged by 4199.56% to $149.9 million in 2023, then tumbled by 90.33% to $14.5 million in 2024, then soared by 1355.04% to $210.9 million in 2025.
  • Business Quant data shows Net Cash Flow for MEDP at $210.9 million in Q4 2025, $239.0 million in Q3 2025, and -$398.1 million in Q2 2025.